Skip to main content
Fig. 5 | BMC Medical Genomics

Fig. 5

From: HELLS serves as a poor prognostic biomarker and its downregulation reserves the malignant phenotype in pancreatic cancer

Fig. 5

Prognostic value of mRNA expression of SMARCAs in pancreatic cancer (Kaplan–Meier Plotter). AC, G The mRNA expression of SMARCA1, SMARCA2, SMARCA3 and SMARCAD1 were significantly correlated with the longer OS of pancreatic cancer patients; F The high mRNA expression of HELLS was significantly associated with shorter OS (P < 0.05); D, E, H The mRNA expression of SMARCA4, SMARCA5, and SMARCAL1 showed no significant correlation with the prognosis of pancreatic cancer (P > 0.05)

Back to article page